PortfoliosLab logoPortfoliosLab logo
CSTL vs. USAR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CSTL vs. USAR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Castle Biosciences, Inc. (CSTL) and USA Rare Earth, Inc (USAR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CSTL achieves a -47.58% return, which is significantly lower than USAR's 135.13% return.


CSTL

1D
3.45%
1M
-20.10%
YTD
-47.58%
6M
-48.26%
1Y
22.02%
3Y*
-3.56%
5Y*
-20.27%
10Y*

USAR

1D
-8.86%
1M
9.38%
YTD
135.13%
6M
99.57%
1Y
208.15%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CSTL vs. USAR - Yearly Performance Comparison


2026 (YTD)202520242023
CSTL
Castle Biosciences, Inc.
-47.58%45.97%23.49%30.79%
USAR
USA Rare Earth, Inc
135.13%3.66%11.13%2.58%

Correlation

The correlation between CSTL and USAR is 0.15, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.15

Correlation (All Time)
Calculated using the full available price history since Jul 18, 2023

0.09

Fundamentals

EPS

CSTL:

-$0.44

USAR:

-$4.85

PS Ratio

CSTL:

1.77

USAR:

7.51

Total Revenue (TTM)

CSTL:

$339.92M

USAR:

$319.83M

Gross Profit (TTM)

CSTL:

$164.74M

USAR:

$253.66M

EBITDA (TTM)

CSTL:

$9.62M

USAR:

-$324.99M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CSTL vs. USAR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CSTL
CSTL Risk / Return Rank: 5353
Overall Rank
CSTL Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
CSTL Sortino Ratio Rank: 5454
Sortino Ratio Rank
CSTL Omega Ratio Rank: 5555
Omega Ratio Rank
CSTL Calmar Ratio Rank: 5050
Calmar Ratio Rank
CSTL Martin Ratio Rank: 5151
Martin Ratio Rank

USAR
USAR Risk / Return Rank: 8080
Overall Rank
USAR Sharpe Ratio Rank: 8484
Sharpe Ratio Rank
USAR Sortino Ratio Rank: 8383
Sortino Ratio Rank
USAR Omega Ratio Rank: 7777
Omega Ratio Rank
USAR Calmar Ratio Rank: 8282
Calmar Ratio Rank
USAR Martin Ratio Rank: 7575
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CSTL vs. USAR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Castle Biosciences, Inc. (CSTL) and USA Rare Earth, Inc (USAR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CSTLUSARDifference
Sharpe ratioReturn per unit of total volatility

-1.36

Sortino ratioReturn per unit of downside risk

-1.63

Omega ratioGain probability vs. loss probability

1.14

1.28

-0.15

Calmar ratioReturn relative to maximum drawdown

0.38

3.03

-2.64

Martin ratioReturn relative to average drawdown

0.88

5.02

-4.14

CSTL vs. USAR - Sharpe Ratio Comparison

The current CSTL Sharpe Ratio is 0.35, which is lower than the USAR Sharpe Ratio of 1.71. The chart below compares the historical Sharpe Ratios of CSTL and USAR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CSTLUSARDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.35

1.71

-1.36

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.27

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.01

0.41

-0.42

Drawdowns

CSTL vs. USAR - Drawdown Comparison

The maximum CSTL drawdown since its inception was -88.02%, which is greater than USAR's maximum drawdown of -69.23%. Use the drawdown chart below to compare losses from any high point for CSTL and USAR.


Loading charts...

Drawdown Indicators


CSTLUSARDifference

Max Drawdown

Largest peak-to-trough decline

-88.02%

-69.23%

-18.79%

Max Drawdown (1Y)

Largest decline over 1 year

-57.83%

-69.23%

+11.40%

Max Drawdown (3Y)

Largest decline over 3 years

-57.83%

Max Drawdown (5Y)

Largest decline over 5 years

-84.97%

Current Drawdown

Current decline from peak

-79.05%

-27.66%

-51.39%

Average Drawdown

Average peak-to-trough decline

-54.66%

-18.60%

-36.06%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.98%

41.62%

-16.64%

Volatility

CSTL vs. USAR - Volatility Comparison

Castle Biosciences, Inc. (CSTL) and USA Rare Earth, Inc (USAR) have volatilities of 30.06% and 30.06%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CSTLUSARDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.06%

30.06%

0.00%

Volatility (6M)

Calculated over the trailing 6-month period

41.23%

81.05%

-39.82%

Volatility (1Y)

Calculated over the trailing 1-year period

63.45%

122.97%

-59.52%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

74.24%

104.42%

-30.18%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

74.36%

104.42%

-30.06%

Dividends

CSTL vs. USAR - Dividend Comparison

Neither CSTL nor USAR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CSTL vs. USAR - Financials Comparison

This section allows you to compare key financial metrics between Castle Biosciences, Inc. and USA Rare Earth, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00M20222023202420252026
83.68M
5.70M
(CSTL) Total Revenue
(USAR) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CSTL and USAR have a correlation of 0.15, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

USAR has higher volatility (30.06%) compared to CSTL (30.06%). In terms of maximum drawdown, CSTL dropped -88.02% vs USAR's -69.23%.

USAR currently has the higher Sharpe Ratio (1.71 vs 0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CSTL and USAR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer